Table of Contents
What changed
Revenue rose 52.1% to $173.3m, but the P&L swung materially negative: profit before tax moved from a $33.5m profit to a $32.5m loss, and net profit after tax went from $36.9m to a $24.1m loss. Operating cash inflow nearly halved to $23.7m from $52.5m. Gross borrowings rose 61.5% to $566.3m, taking net debt to roughly $548.1m from $333.9m. Total assets expanded to $2.47bn and equity to $1.05bn. The interim dividend was cut 40.5% to 1.25cps from 2.10cps. Segment mix shifted toward retirement, which rose to about 30% of revenue from 17%, while care's share fell from 82% to 70%.
What matters
- Earnings quality flipped, not just softened. PBT fell 197.2% versus a 165.3% fall in NPAT; the gap reflects an $8.4m current-period tax benefit that cushioned the reported loss. PBT is the cleaner read and it is decisively negative. Return on equity went from +4.0% to -2.5%.
- Balance sheet is the direction of travel. Capex stayed very heavy at $113.3m against materially weaker operating cash, so pre-lease free cash flow deteriorated to -$89.6m from -$63.1m. The gap was funded by borrowing: net debt climbed roughly $214m year-on-year. The equity base grew, but leverage is clearly weakening.
- Dividend cut corroborates the cash story. A 40.5% DPS cut alongside negative pre-lease FCF signals management is preserving cash rather than sustaining the prior distribution level through debt.
Expectations
No quantitative guidance, forward-work balance, or stated targets were disclosed in the supplied material. HY22 revenue was roughly evenly split across FY22 (HY22 was 49.3% of full-year revenue), while HY22 NPAT was more first-half weighted (60.4% of full-year). Current half-year revenue annualises to $346.5m versus FY22 revenue of $231.1m, but with the current half in loss and prior full-year earnings heavily reliant on first-half contribution, revenue annualisation does not translate into an earnings read. The release supports a scaling-up top-line narrative; it does not support any directional statement on full-year profitability.
Quality of result
Low durability on the earnings line. The reported NPAT loss is flattered by an $8.4m tax benefit, so the underlying operating deterioration is larger than the headline. Operating cash conversion deteriorated materially — OCF fell 54.8% while revenue grew 52.1%. Cash at bank rose only $1.5m year-on-year despite $23.7m of operating inflows, because investing outflows remained very large and were effectively funded by a ~$215m increase in gross borrowings. Segment-level profit for the current half was not disclosed, and underlying EBITDA / underlying NPAT reconciliations referenced in prior-period commentary were not provided this time, limiting transparency on how much of the swing is non-cash fair-value movement versus cash operating margin compression.
Unresolved
- What drove the pre-tax swing of roughly $66m — fair-value/revaluation movements on investment property, interest cost on the larger debt stack, care-segment operating margin, or a mix?
- What is underlying EBITDA for HY23, and how does it reconcile to the statutory loss? No current-period non-GAAP reconciliation was supplied.
- What is the forward sales/settlement pipeline, and does it support continued capex at ~$113m per half?
- Are there debt covenants or headroom constraints given net debt is now $548.1m with OCF running at $23.7m per half?
- What is the capital-allocation plan if pre-lease FCF remains deeply negative — further dividend resets, equity, or asset sales?
This briefing cannot assess underlying (non-GAAP) profitability, segment-level margins for the current period, or covenant headroom, because those disclosures were not provided in the supplied extraction.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $173.3m | $113.9m | +52.1% ↑ |
| Net profit after tax | −$24.1m | $36.9m | -165.3% ↓ |
| Net cash inflow from operating activities | $23.7m | $52.5m | -54.8% ↓ |
| Interim dividend per share | 1.3c | 2.1c | -40.5% ↓ |
| Profit before tax | −$32.5m | $33.5m | -197.2% ↓ |
| Total assets | $2.5b | $2.1b | +19.8% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Care | $121m | $93.3m | — | -12.1pp |
| Retirement | $52.3m | $19.7m | — | +12.9pp |
| Other | — | $0.86m | — | n/a |
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | -10.4% | current loss period |
| FCF pre-lease | −$89.6m | −$63.1m | −$26.5m |
| FCF / NPAT | 371.5% | -170.9% | complementary conversion metric |
| Capex % revenue | 65.4% | 101.5% | — |
| Capex | −$113.3m | −$115.6m | +$2.3m |
| Debtor days | 11.5 | — | — |
| Trade debtors | $11m | — | — |
| Net debt | $548.1m | $333.9m | +$214.1m |
| Gross borrowings | $566.3m | $350.7m | +$215.6m |
| ROE (annualised) | -2.5% | 4.0% | Weakening |
| HY22 share of FY22 revenue | 49.3% | — | Other half was 50.7% |
| HY22 share of FY22 NPAT | 60.4% | — | Other half was 39.6% |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.